0001467652-15-000003.txt : 20150220 0001467652-15-000003.hdr.sgml : 20150220 20150220125310 ACCESSION NUMBER: 0001467652-15-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150220 DATE AS OF CHANGE: 20150220 EFFECTIVENESS DATE: 20150220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neos Therapeutics, Inc. CENTRAL INDEX KEY: 0001467652 IRS NUMBER: 270395455 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-231561 FILM NUMBER: 15634733 BUSINESS ADDRESS: STREET 1: 2940 N. HIGHWAY 360 STREET 2: SUITE 400 CITY: GRAND PRAIRIE STATE: TX ZIP: 75050 BUSINESS PHONE: 972.408.1360 MAIL ADDRESS: STREET 1: 2940 N. HIGHWAY 360 STREET 2: SUITE 400 CITY: GRAND PRAIRIE STATE: TX ZIP: 75050 D/A 1 primary_doc.xml X0707 D/A LIVE 0001467652 Neos Therapeutics, Inc. 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX TEXAS 75050 972.408.1360 DELAWARE None None Corporation true Alan Heller 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Director Chairman Vipin Garg 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer Director President and Chief Executive Officer Bryant Fong 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Director Ralph Iannelli 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Director Greg Robitaille 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Director Edward Schnipper 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Director Mark Tengler 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer Chief Technology Officer Richard Eisenstadt 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer Chief Financial Officer and Secretary Russ McMahen 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer VP Research and Development Margaret Cabano 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer VP Operations Asif Mughal 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer VP Quality Assurance Steven Lutz 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer VP Sales Dorothy Engelking 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer VP Regulatory Affairs Carolyn Sikes 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer VP Clinical Affairs Stacie Switzer 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer Assistant Secretary Arlen Ewart 2940 N. HIGHWAY 360 Suite 400 Grand Prairie TX TEXAS 75050 Executive Officer Controller Pharmaceuticals Decline to Disclose 06b true 0001467652-15-000001 2014-12-30 false true true false 0 20624355 20624355 0 Most investors participating in this offering receive warrant with coverage equal to 50% of such investor's amount purchased in this offering. false 27 0 0 0 false Neos Therapeutics, Inc. /s/ Richard Eisenstadt Richard Eisenstadt Chief Financial Officer 2015-02-19